ÂÜÀòÂÒÂ×

Juliet Labadorf, CPA has a strong background in financial planning and analysis. Juliet is currently working as the Senior Director of Financial Planning & Analysis at Sionna Therapeutics since July 2023. Prior to this, they held the position of Director of Financial Planning & Analysis at Sionna Therapeutics from January 2022 to July 2023. Before joining Sionna Therapeutics, they worked as an Associate Director of Corporate Finance at Cullinan Oncology from December 2020 to December 2021. Earlier in their career, they worked at BlueRock Therapeutics as a Senior Manager of Financial Planning & Analysis and then as a Manager of FP&A from December 2018 to December 2020. Juliet gained experience as a Financial Analyst in FP&A at Squarespace from July 2017 to July 2018. Additionally, they worked at HBO as a Senior in Distribution Operations & Reporting from March 2016 to July 2017 and as a Distribution Operations & Reporting staff from November 2014 to March 2016. Finally, they started their career at Deloitte as an Audit Senior Assistant from September 2013 to October 2014, and previously as an Audit & Assurance Intern from June 2012 to August 2012.

Juliet Labadorf, CPA, began their education at Lehigh University College of Business from 2008 to 2012, where they earned a Bachelor of Science (BS) degree. In 2011, they also attended Tel Aviv University for Middle Eastern Studies. Juliet then pursued further education at Yeshiva University from 2012 to 2013, where they obtained a Master of Science (MS) degree in Accountancy.

Juliet Labadorf is additionally certified as a Certified Public Accountant by the New York State Education Department. Specific dates regarding the certification have not been provided.